Latest Breaking News On - Sharif alhajlah - Page 1 : comparemela.com

"This drug has the potential to be a first-in-class treatment against some of the key pathological drivers of spinal cord injury and could revolutionise the prospects for recovery."

United kingdomZubair ahmedAdam thompsonSharif alhajlahRebecca faircloughRebeccaj faircloughAdamm thompsonOphthalmology departmentUniversity of birmingham enterpriseUniversity of birminghamInstitute of inflammationTranslational medicineProfessor zubair ahmedOphthalmology sectionBirmingham enterpriseAstrazeneca united kingdom